COMBINATION THERAPIES FOR TREATMENT OF HER2 CANCER

Provided are combination therapies comprising inavolisib (a.k.a. GDC-0077) and other HER2-targeted therapies (e.g., pertuzumab and trastuzumab) for the treatment of HER2-positive cancers; and methods of treating HER2 positive (HER2+) cancers in a patient (preferably a patient with a PIK3CA mutant br...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	SONG, KYUNG WHA, JOO, STEPHANIE ROYER, THANOPOULOU, EIRINI, SCHUTZMAN, JENNIFER LEE, SONG, CHUNYAN, WARBURTON, SIMON PETER, DEY, ANWESHA
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!